[日本語] English
文献
- EMDB/PDB/SASBDBから引用されている文献のデータベース -

+
検索条件

キーワード
構造解析手法
著者・登録者
ジャーナル
IF

-
Structure paper

タイトルPanDDA analysis group deposition of models with modelled events (e.g. bound ligands)
ジャーナル・号・ページTo Be Published
掲載日2018年5月15日 (構造データの登録日)
著者Krojer, T. / Talon, R. / Fairhead, M. / Diaz Saez, L. / Bradley, A.R. / Aimon, A. / Collins, P. / Brandao-Neto, J. / Douangamath, A. / Ruda, G.F. ...Krojer, T. / Talon, R. / Fairhead, M. / Diaz Saez, L. / Bradley, A.R. / Aimon, A. / Collins, P. / Brandao-Neto, J. / Douangamath, A. / Ruda, G.F. / Szommer, T. / Srikannathasan, V. / Elkins, J. / Spencer, J. / London, N. / Nelson, A. / Brennan, P.E. / Huber, K. / Bountra, C. / Arrowsmith, C.H. / Edwards, A. / von Delft, F.
リンクPubMedで検索
手法X線回折
解像度1.05 - 2.27 Å
構造データ

PDB-5qgg:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with FMOPL000693a
手法: X-RAY DIFFRACTION / 解像度: 1.91 Å

PDB-5qgh:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with FMOPL000420a
手法: X-RAY DIFFRACTION / 解像度: 1.82 Å

PDB-5qgi:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with FMOPL000710a
手法: X-RAY DIFFRACTION / 解像度: 1.95 Å

PDB-5qgj:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with FMOPL000706a
手法: X-RAY DIFFRACTION / 解像度: 1.95 Å

PDB-5qgk:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with FMOPL000679a
手法: X-RAY DIFFRACTION / 解像度: 1.81 Å

PDB-5qgl:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with FMOPL000275a
手法: X-RAY DIFFRACTION / 解像度: 2.27 Å

PDB-5qgm:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with OX-160
手法: X-RAY DIFFRACTION / 解像度: 1.96 Å

PDB-5qgn:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with OX-210
手法: X-RAY DIFFRACTION / 解像度: 1.95 Å

PDB-5qgo:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with OX-220
手法: X-RAY DIFFRACTION / 解像度: 1.82 Å

PDB-5qgp:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with OX-221
手法: X-RAY DIFFRACTION / 解像度: 2.09 Å

PDB-5qgq:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with OX-65
手法: X-RAY DIFFRACTION / 解像度: 1.95 Å

PDB-5qgr:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with FMOPL000022a
手法: X-RAY DIFFRACTION / 解像度: 1.96 Å

PDB-5qgs:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with FMOPL000476a
手法: X-RAY DIFFRACTION / 解像度: 1.55 Å

PDB-5qgt:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with FMOPL000609a
手法: X-RAY DIFFRACTION / 解像度: 1.97 Å

PDB-5qgu:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with FMOPL000747a
手法: X-RAY DIFFRACTION / 解像度: 1.71 Å

PDB-5qgv:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with UNUYB062989
手法: X-RAY DIFFRACTION / 解像度: 1.59 Å

PDB-5qgw:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with NUOOA000154
手法: X-RAY DIFFRACTION / 解像度: 1.94 Å

PDB-5qgx:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with NUOOA000155
手法: X-RAY DIFFRACTION / 解像度: 1.61 Å

PDB-5qgy:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with NUOOA000158
手法: X-RAY DIFFRACTION / 解像度: 1.72 Å

PDB-5qgz:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with NUOOA000161
手法: X-RAY DIFFRACTION / 解像度: 1.65 Å

PDB-5qh0:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with NUOOA000180
手法: X-RAY DIFFRACTION / 解像度: 1.57 Å

PDB-5qh1:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with NUOOA000181
手法: X-RAY DIFFRACTION / 解像度: 1.65 Å

PDB-5qh2:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with NUOOA000188
手法: X-RAY DIFFRACTION / 解像度: 1.74 Å

PDB-5qh3:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with NUOOA000191
手法: X-RAY DIFFRACTION / 解像度: 1.65 Å

PDB-5qh4:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with NUOOA000220a
手法: X-RAY DIFFRACTION / 解像度: 1.67 Å

PDB-5qh5:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with NUOOA000224a
手法: X-RAY DIFFRACTION / 解像度: 1.85 Å

PDB-5qh6:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with NUOOA000259a
手法: X-RAY DIFFRACTION / 解像度: 2 Å

PDB-5qh7:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with NUOOA000194a
手法: X-RAY DIFFRACTION / 解像度: 1.74 Å

PDB-5qh8:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with PCM-0102558
手法: X-RAY DIFFRACTION / 解像度: 1.75 Å

PDB-5qh9:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with PCM-0102716
手法: X-RAY DIFFRACTION / 解像度: 1.72 Å

PDB-5qhb:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with RK4-332
手法: X-RAY DIFFRACTION / 解像度: 1.57 Å

PDB-5qhc:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with RK4-337
手法: X-RAY DIFFRACTION / 解像度: 2.21 Å

PDB-5qhe:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with RK4-350
手法: X-RAY DIFFRACTION / 解像度: 1.74 Å

PDB-5qhf:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with NUOOA000301a
手法: X-RAY DIFFRACTION / 解像度: 1.67 Å

PDB-5qhg:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with NU000442a
手法: X-RAY DIFFRACTION / 解像度: 1.92 Å

PDB-5qhh:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with NU000443a
手法: X-RAY DIFFRACTION / 解像度: 1.52 Å

PDB-5qhi:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of human FAM83B in complex with FMOPL000271a
手法: X-RAY DIFFRACTION / 解像度: 1.73 Å

PDB-5qhj:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of human FAM83B in complex with FMOPL000709a
手法: X-RAY DIFFRACTION / 解像度: 1.68 Å

PDB-5qhk:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of human FAM83B in complex with FMOPL000010a
手法: X-RAY DIFFRACTION / 解像度: 1.61 Å

PDB-5qhl:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of human FAM83B in complex with FMOPL000551a
手法: X-RAY DIFFRACTION / 解像度: 1.68 Å

PDB-5qhm:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of human FAM83B in complex with OX-145
手法: X-RAY DIFFRACTION / 解像度: 1.79 Å

PDB-5qhn:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of human FAM83B in complex with FMOPL000622a
手法: X-RAY DIFFRACTION / 解像度: 1.73 Å

PDB-5qho:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of human FAM83B in complex with FMOPL000010a
手法: X-RAY DIFFRACTION / 解像度: 1.66 Å

PDB-5qhp:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of human FAM83B in complex with FMOPL000554a
手法: X-RAY DIFFRACTION / 解像度: 2.06 Å

PDB-5qhq:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of human FAM83B in complex with FMOPL000574a
手法: X-RAY DIFFRACTION / 解像度: 1.96 Å

PDB-5qhr:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of human FAM83B in complex with FMOPL000635a
手法: X-RAY DIFFRACTION / 解像度: 1.68 Å

PDB-5qhs:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of human FAM83B in complex with FF000014a
手法: X-RAY DIFFRACTION / 解像度: 1.95 Å

PDB-5qhu:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of human PARP14 Macrodomain 3 in complex with FMSOA000341b
手法: X-RAY DIFFRACTION / 解像度: 1.05 Å

PDB-5qhw:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of human PARP14 Macrodomain 3 in complex with FMOPL000347a
手法: X-RAY DIFFRACTION / 解像度: 1.12 Å

PDB-5qhx:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of human PARP14 Macrodomain 3 in complex with FMOPL000278a
手法: X-RAY DIFFRACTION / 解像度: 1.11 Å

PDB-5qhy:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of human PARP14 Macrodomain 3 in complex with FMOPL000462a
手法: X-RAY DIFFRACTION / 解像度: 1.17 Å

PDB-5qhz:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of human PARP14 Macrodomain 3 in complex with FMOPL000385a
手法: X-RAY DIFFRACTION / 解像度: 1.15 Å

PDB-5qi0:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of human PARP14 Macrodomain 3 in complex with FMOPL000352a
手法: X-RAY DIFFRACTION / 解像度: 1.05 Å

PDB-5qi1:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of human PARP14 Macrodomain 3 in complex with FMOPL000474a
手法: X-RAY DIFFRACTION / 解像度: 1.05 Å

PDB-5qi2:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of human PARP14 Macrodomain 3 in complex with FMOPL000110a
手法: X-RAY DIFFRACTION / 解像度: 1.08 Å

PDB-5qi3:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of human PARP14 Macrodomain 3 in complex with FMOPL000475a
手法: X-RAY DIFFRACTION / 解像度: 1.05 Å

PDB-5qi5:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of human PARP14 Macrodomain 3 in complex with FMOPL000633a
手法: X-RAY DIFFRACTION / 解像度: 1.05 Å

PDB-5qi7:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of human PARP14 Macrodomain 3 in complex with FMOPL000506a
手法: X-RAY DIFFRACTION / 解像度: 1.05 Å

PDB-5qia:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of human PARP14 Macrodomain 3 in complex with FMOPL000242a
手法: X-RAY DIFFRACTION / 解像度: 1.14 Å

PDB-5qib:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of HAO1 in complex with FMOPL000388a
手法: X-RAY DIFFRACTION / 解像度: 1.48 Å

PDB-5qic:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of HAO1 in complex with Z30620520
手法: X-RAY DIFFRACTION / 解像度: 1.34 Å

PDB-5qid:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of HAO1 in complex with Z1787627869
手法: X-RAY DIFFRACTION / 解像度: 1.45 Å

PDB-5qie:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of HAO1 in complex with Z2856434894
手法: X-RAY DIFFRACTION / 解像度: 1.34 Å

PDB-5qif:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of HAO1 in complex with Z31792168
手法: X-RAY DIFFRACTION / 解像度: 1.2 Å

PDB-5qig:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of HAO1 in complex with Z1407672867
手法: X-RAY DIFFRACTION / 解像度: 1.42 Å

PDB-5qih:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of HAO1 in complex with Z2697514548
手法: X-RAY DIFFRACTION / 解像度: 1.33 Å

PDB-5qj4:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z1827602749
手法: X-RAY DIFFRACTION / 解像度: 1.89 Å

PDB-5qj6:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z1614545742
手法: X-RAY DIFFRACTION / 解像度: 1.65 Å

PDB-5qj7:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z32327641
手法: X-RAY DIFFRACTION / 解像度: 1.56 Å

PDB-5qj8:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z2856434829
手法: X-RAY DIFFRACTION / 解像度: 1.76 Å

PDB-5qj9:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z768399682
手法: X-RAY DIFFRACTION / 解像度: 1.85 Å

PDB-5qja:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z1497321453
手法: X-RAY DIFFRACTION / 解像度: 1.64 Å

PDB-5qjb:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z1787627869
手法: X-RAY DIFFRACTION / 解像度: 1.66 Å

PDB-5qjc:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z755044716
手法: X-RAY DIFFRACTION / 解像度: 1.47 Å

PDB-5qjd:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z240297434
手法: X-RAY DIFFRACTION / 解像度: 1.61 Å

PDB-5qje:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z275181224
手法: X-RAY DIFFRACTION / 解像度: 1.75 Å

PDB-5qjf:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z52425517
手法: X-RAY DIFFRACTION / 解像度: 1.63 Å

PDB-5qjg:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z44567722
手法: X-RAY DIFFRACTION / 解像度: 1.57 Å

PDB-5qjh:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z375990520
手法: X-RAY DIFFRACTION / 解像度: 2.03 Å

PDB-5qji:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z1899842917
手法: X-RAY DIFFRACTION / 解像度: 1.69 Å

PDB-5qjj:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z24758179
手法: X-RAY DIFFRACTION / 解像度: 1.71 Å

PDB-5qjk:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z373221060
手法: X-RAY DIFFRACTION / 解像度: 1.65 Å

PDB-5qjl:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z56983806
手法: X-RAY DIFFRACTION / 解像度: 1.66 Å

PDB-5qjm:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z328695024
手法: X-RAY DIFFRACTION / 解像度: 1.75 Å

PDB-5qjn:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z1439422127
手法: X-RAY DIFFRACTION / 解像度: 1.77 Å

PDB-5qjo:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z57292369
手法: X-RAY DIFFRACTION / 解像度: 1.98 Å

PDB-5qjp:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z1578665941
手法: X-RAY DIFFRACTION / 解像度: 1.5 Å

PDB-5qjq:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z56791867
手法: X-RAY DIFFRACTION / 解像度: 1.55 Å

PDB-5qjr:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z220816104
手法: X-RAY DIFFRACTION / 解像度: 1.62 Å

PDB-5qjs:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z979145504
手法: X-RAY DIFFRACTION / 解像度: 1.58 Å

PDB-5qjt:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z969560582
手法: X-RAY DIFFRACTION / 解像度: 1.62 Å

PDB-5qju:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z906021418
手法: X-RAY DIFFRACTION / 解像度: 1.77 Å

PDB-5qjv:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z281802060
手法: X-RAY DIFFRACTION / 解像度: 1.61 Å

PDB-5qjw:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z198194396
手法: X-RAY DIFFRACTION / 解像度: 1.57 Å

PDB-5qjx:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z2856434778
手法: X-RAY DIFFRACTION / 解像度: 1.73 Å

PDB-5qjy:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z94597856
手法: X-RAY DIFFRACTION / 解像度: 1.77 Å

PDB-5qjz:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z1696822287
手法: X-RAY DIFFRACTION / 解像度: 1.52 Å

PDB-5qk0:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z1270312110
手法: X-RAY DIFFRACTION / 解像度: 1.44 Å

PDB-5qk1:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z2027049478
手法: X-RAY DIFFRACTION / 解像度: 1.49 Å

PDB-5qk2:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z54628578
手法: X-RAY DIFFRACTION / 解像度: 1.65 Å

PDB-5qk3:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z239136710
手法: X-RAY DIFFRACTION / 解像度: 1.71 Å

PDB-5qk4:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z44590919
手法: X-RAY DIFFRACTION / 解像度: 1.62 Å

PDB-5qk5:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z1267773786
手法: X-RAY DIFFRACTION / 解像度: 1.63 Å

PDB-5qk6:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z1343633025
手法: X-RAY DIFFRACTION / 解像度: 1.51 Å

PDB-5qk7:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z1918536193
手法: X-RAY DIFFRACTION / 解像度: 1.66 Å

PDB-5qk8:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z1271660837
手法: X-RAY DIFFRACTION / 解像度: 1.71 Å

PDB-5qk9:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z102895082
手法: X-RAY DIFFRACTION / 解像度: 1.56 Å

PDB-5qka:
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z2377835233
手法: X-RAY DIFFRACTION / 解像度: 1.55 Å

化合物

ChemComp-ACT:
ACETATE ION / 酢酸イオン

ChemComp-DMS:
DIMETHYL SULFOXIDE / 2-チアプロパン2-オキシド / DMSO, 沈殿剤*YM

ChemComp-H2G:
(2S)-1-{[(5-methylthiophen-2-yl)methyl]amino}propan-2-ol

ChemComp-HOH:
WATER

ChemComp-H2D:
(2R)-N-(1,2-oxazol-3-yl)-2-phenylbutanamide

ChemComp-B0V:
2-methoxy-~{N}-(2,4,6-trimethylphenyl)ethanamide

ChemComp-H1A:
2-ethyl-N-(2-hydroxyphenyl)butanamide

ChemComp-H0S:
N-(4-methylphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

ChemComp-H5A:
3,4,5-trimethoxybenzoic acid / 3,4,5-トリメトキシ安息香酸

ChemComp-H4Y:
1-(4'-methoxy[1,1'-biphenyl]-2-yl)pyrrolidin-2-one

ChemComp-H4D:
3-borono-5-{[(thiophen-2-yl)acetyl]amino}benzoic acid

ChemComp-H4A:
(3aR,4R,6R,7R,8aR)-6-phenyloctahydro-1H-3a,7-epiminocyclohepta[c]pyrrol-4-ol

ChemComp-H3Y:
(3aR,4S,6R,7R,8aR)-6-phenyloctahydro-1H-3a,7-epiminocyclohepta[c]pyrrol-4-ol

ChemComp-H3J:
3-methyl-2-[(pyridin-3-yl)oxy]cyclopenta-2,4-dien-1-one

ChemComp-H0J:
5-(pyridin-2-yl)thiophene-2-carbothioamide

ChemComp-H0D:
N-(4-chlorophenyl)-N'-[(2R)-1-hydroxybutan-2-yl]urea

ChemComp-H04:
1-(2-ethoxyphenyl)piperazine / 1-(2-エトキシフェニル)ピペラジン

ChemComp-H3G:
(4-tert-butylpiperidin-1-yl)(phenyl)methanone

ChemComp-H3A:
N-(3-chlorophenyl)-2-(3-methoxyphenyl)acetamide

ChemComp-H2Y:
2-(4-methoxyphenyl)-N-(pyridin-3-yl)acetamide

ChemComp-H2J:
N-(3-chlorophenyl)-2-(4-methoxyphenyl)acetamide

ChemComp-H1Y:
N-(3-chlorophenyl)-2-phenylacetamide / N-(3-クロロフェニル)ベンゼンアセトアミド

ChemComp-H1J:
N-(3-chlorophenyl)-2-(4-fluorophenyl)acetamide

ChemComp-H0P:
2-(3-hydroxyphenyl)-N-(pyridin-3-yl)acetamide

ChemComp-H5G:
N-(3-chlorophenyl)-2-(3-hydroxyphenyl)acetamide

ChemComp-H54:
2-(3-methylphenyl)-N-(pyridin-3-yl)acetamide

ChemComp-H4G:
2-(2,4-difluorophenyl)-N-(pyridin-3-yl)acetamide

ChemComp-H47:
2-(3-methoxyphenyl)-N-(1,2-oxazol-3-yl)acetamide

ChemComp-H3V:
N-(1,2-oxazol-3-yl)-2-phenylacetamide

ChemComp-H0M:
2-(3-hydroxyphenyl)-N-(pyridin-2-yl)acetamide

ChemComp-H0G:
2-(3-methylphenyl)-N-(1,2-oxazol-3-yl)acetamide

ChemComp-H0A:
1-[(2S)-2-(4-methoxyphenyl)-2,3,6,7-tetrahydro-1H-azepin-1-yl]ethan-1-one

ChemComp-GZY:
1-[(2S)-2-(3-methoxyphenyl)pyrrolidin-1-yl]ethan-1-one

ChemComp-H31:
1-(4'-methyl[1,1'-biphenyl]-2-yl)pyrrolidin-2-one / 1-(4′-メチル-2-ビフェニリル)ピロリジン-2-オン

ChemComp-H2M:
1-[3'-(trifluoromethyl)[1,1'-biphenyl]-2-yl]-1,3-dihydro-2H-pyrrol-2-one

ChemComp-H1P:
1-(4'-fluoro[1,1'-biphenyl]-2-yl)-1,3-dihydro-2H-pyrrol-2-one

ChemComp-H1G:
2-(4-methoxyphenyl)-N-{5-[2-oxo-2-(3-oxopiperazin-1-yl)ethoxy]pyridin-3-yl}acetamide

ChemComp-H17:
2-{3-[(2R)-1-acryloylpyrrolidin-2-yl]phenyl}-N-(3-chlorophenyl)acetamide

ChemComp-H5D:
2-{3-[(2S)-1-acetylpyrrolidin-2-yl]phenyl}-N-(3-chlorophenyl)acetamide

ChemComp-IOD:
IODIDE ION / ヨ-ジド

ChemComp-EDO:
1,2-ETHANEDIOL / エチレングリコ-ル

ChemComp-GOJ:
ethyl 1~{H}-pyrazole-4-carboxylate / 1H-ピラゾ-ル-4-カルボン酸エチル

ChemComp-GOV:
(2S)-1-{[(2H-1,3-benzodioxol-5-yl)methyl]amino}propan-2-ol

ChemComp-GOY:
di(piperidin-1-yl)methanone / ジピペリジノケトン

ChemComp-GQ7:
[5-(4-aminophenyl)furan-2-yl]methanol

ChemComp-GQA:
1-methyl-3-oxidanyl-pyridine-2-thione / 1-メチル-3-ヒドロキシピリジン-2(1H)-チオン

ChemComp-GQJ:
methyl (2~{S},4~{R})-1-(furan-2-ylcarbonyl)-4-oxidanyl-pyrrolidine-2-carboxylate

ChemComp-GQM:
5-methoxy-2-(1~{H}-pyrazol-3-yl)phenol

ChemComp-GQP:
1-[(4-fluorophenyl)methyl]benzimidazole / 1-(4-フルオロベンジル)-1H-ベンゾイミダゾ-ル

ChemComp-GQS:
N-(3-fluorophenyl)-5-methyl-1,3,4-thiadiazol-2-amine

ChemComp-GQV:
1-methyl-3-oxidanyl-pyridin-2-one / 3-ヒドロキシ-1-メチルピリジン-2(1H)-オン

ChemComp-CL:
Unknown entry / クロリド

ChemComp-9KS:
N-(2-hydroxyphenyl)acetamide / N-(2-ヒドロキシフェニル)アセトアミド

ChemComp-GRV:
2-methyl-~{N}-(2-methylpropyl)imidazo[1,2-a]pyridine-3-carboxamide

ChemComp-GRY:
~{N}1-(4,6-dimethylpyrimidin-2-yl)benzene-1,4-diamine

ChemComp-GT4:
~{N}-(4-hydroxyphenyl)-2-methoxy-ethanamide

ChemComp-GT7:
2-cyano-~{N}-cyclohexyl-ethanamide / N-シクロヘキシル-2-シアノアセトアミド

ChemComp-GTJ:
~{N}-(1-propylbenzimidazol-2-yl)propanamide

ChemComp-GUG:
~{N}-propan-2-ylquinoline-2-carboxamide

ChemComp-GUV:
1-methyl-3-[3-(2-methylpyrimidin-4-yl)phenyl]urea

ChemComp-GUY:
~{N}-(1-propyl-1,2,3,4-tetrazol-5-yl)furan-2-carboxamide

ChemComp-GV4:
2-cyano-~{N}-(1,3,5-trimethylpyrazol-4-yl)ethanamide

ChemComp-GVV:
~{N}-(4-methyl-2-oxidanyl-phenyl)propanamide

ChemComp-GWA:
~{N}-(3-acetamidophenyl)-2-methoxy-ethanamide

ChemComp-FNR:
1-DEOXY-1-(7,8-DIMETHYL-2,4-DIOXO-3,4-DIHYDRO-2H-BENZO[G]PTERIDIN-1-ID-10(5H)-YL)-5-O-PHOSPHONATO-D-RIBITOL / 還元型フラビンモノヌクレオチド

ChemComp-GX7:
5-(cyclohexylamino)pyrimidine-2,4(1H,3H)-dione / 5-(シクロヘキシルアミノ)ウラシル

ChemComp-FMN:
FLAVIN MONONUCLEOTIDE / FMN

ChemComp-GX4:
cyclopropyl-[4-(4-fluorophenyl)piperazin-1-yl]methanone

ChemComp-GWY:
5-chloranyl-~{N}-methyl-~{N}-[[(3~{S})-oxolan-3-yl]methyl]pyrimidin-4-amine

ChemComp-GWV:
~{N},~{N}-dimethyl-4-[(propan-2-ylamino)methyl]aniline

ChemComp-GWS:
2-cyclohexyl-~{N}-pyridin-3-yl-ethanamide

ChemComp-GWP:
2-cyclopropyl-1~{H}-imidazole-4-carboxamide

ChemComp-GWG:
1-methylindazole-3-carboxamide

ChemComp-MG:
Unknown entry / マグネシウムジカチオン

ChemComp-K04:
(2S,3S)-3-methyl-N-(1,2,3-thiadiazol-5-yl)tetrahydrofuran-2-carboxamide (non-preferred name)

ChemComp-JMM:
[4-(cyclopropanecarbonyl)piperazin-1-yl](furan-2-yl)methanone

ChemComp-ELQ:
[3,4-bis(fluoranyl)phenyl]-(4-methylpiperazin-1-yl)methanone

ChemComp-K0D:
[(2R,5S)-2,5-dimethylmorpholin-4-yl](1,2,5-thiadiazol-3-yl)methanone

ChemComp-K0A:
(2,5-dimethyl-1,3-thiazol-4-yl)(pyrrolidin-1-yl)methanone

ChemComp-K07:
5-chloro-N-methyl-N-{[(3R)-oxolan-3-yl]methyl}pyrimidin-4-amine

ChemComp-K0J:
N-ethyl-1H-1,2,3-triazole-4-carboxamide

ChemComp-K0M:
3-methyl-N-(1-methyl-1H-pyrazol-3-yl)-1,2-oxazole-5-carboxamide

ChemComp-K0P:
N-[(1-ethyl-1H-pyrazol-4-yl)methyl]pyridine-3-carboxamide

ChemComp-K0S:
N-(5-propyl-1,3,4-thiadiazol-2-yl)pyridine-2-carboxamide

ChemComp-K0V:
methyl 1-(tert-butylcarbamoyl)piperidine-4-carboxylate

ChemComp-K0Y:
methyl N-(5-methyl-1,2-oxazole-3-carbonyl)glycinate

ChemComp-K1A:
3-[(3,5-dimethyl-1,2-oxazol-4-yl)methyl]-5-methyl-1,3,4-thiadiazol-2(3H)-one

ChemComp-6SU:
methyl 3-(methylsulfonylamino)benzoate / 3-(メチルスルホニルアミノ)安息香酸メチル

ChemComp-K1D:
6-(azetidin-1-yl)-9H-purine

ChemComp-JJM:
1-methyl-N-(3-methylphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

ChemComp-K1G:
N,1-dimethyl-N-(propan-2-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine

ChemComp-K1J:
(2S,3R)-2,3-dimethyl-4-(3-methyl-1,2,4-thiadiazol-5-yl)morpholine

ChemComp-K41:
2-methyl-N-(2-methyl-2H-tetrazol-5-yl)propanamide

ChemComp-K1P:
1-(3-methyl-1,2,4-thiadiazol-5-yl)-1,4-diazepane

ChemComp-K1S:
N,N-diethyl-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine / トラピジル / アンタゴニスト*YM

ChemComp-K1V:
(3R)-1-acetylpiperidine-3-carboxamide

ChemComp-K1Y:
methyl (2-methyl-4-phenyl-1,3-thiazol-5-yl)carbamate

ChemComp-K24:
N,2-dimethyl-1,3-thiazole-5-carboxamide

ChemComp-K2G:
5-chloro-2-(propan-2-yl)pyrimidine-4-carboxamide

ChemComp-K2J:
4-methoxy-N-methylpyrimidin-2-amine

ChemComp-K2M:
4-(furan-2-carbonyl)piperazine-1-carboxamide

ChemComp-K2P:
2-(trifluoromethoxy)benzoic acid / 2-(トリフルオロメトキシ)安息香酸

ChemComp-K2S:
N,N,3,5-tetramethyl-1H-pyrazole-4-sulfonamide

ChemComp-K2V:
(1R)-1-[4-(pyrimidin-5-yl)phenyl]ethan-1-amine

ChemComp-K31:
2-(3,5-dimethyl-1H-pyrazol-4-yl)aniline

ChemComp-K34:
5-(1,3-thiazol-2-yl)-1H-1,2,4-triazole

ChemComp-JH4:
N-methylpyrimidin-2-amine / 2-(メチルアミノ)ピリミジン

ChemComp-K3A:
N-(5-methyl-1H-pyrazol-3-yl)acetamide / 3-(アセチルアミノ)-5-メチル-1H-ピラゾ-ル

ChemComp-K3D:
4-acetyl-N-ethylpiperazine-1-carboxamide

ChemComp-K3J:
N-ethyl-6-methylpyridazin-3-amine

ChemComp-K3M:
2-fluoro-4-methylbenzamide

ChemComp-K3P:
5-chloro-4-[(1-methyl-1H-pyrazol-4-yl)oxy]pyrimidine

ChemComp-K3S:
N-[(1-methyl-1H-1,2,3-triazol-4-yl)methyl]ethanamine

ChemComp-K3V:
7,8-dimethoxyphthalazin-1(2H)-one / 7,8-ジメトキシ-1,2-ジヒドロフタラジン-1-オン

ChemComp-K3Y:
1-methyl-3-[(3R)-piperidin-3-yl]-1H-pyrazole-4-carboxamide

由来
  • homo sapiens (ヒト)
キーワードHYDROLASE / PanDDA / SGC - Diamond I04-1 fragment screening / NUDIX domain / XChemExplorer / PROTEIN BINDING / DUF1669 domain / TRANSFERASE / macrodomain / OXIDOREDUCTASE / HAO1 / NUDT5

+
万見文献について

-
お知らせ

-
2022年2月9日: EMDBエントリの付随情報ファイルのフォーマットが新しくなりました

EMDBエントリの付随情報ファイルのフォーマットが新しくなりました

  • EMDBのヘッダファイルのバージョン3が、公式のフォーマットとなりました。
  • これまでは公式だったバージョン1.9は、アーカイブから削除されます。

関連情報:EMDBヘッダ

外部リンク:wwPDBはEMDBデータモデルのバージョン3へ移行します

-
2020年8月12日: 新型コロナ情報

新型コロナ情報

URL: https://pdbj.org/emnavi/covid19.php

新ページ: EM Navigatorに新型コロナウイルスの特設ページを開設しました。

関連情報:Covid-19情報 / 2020年3月5日: 新型コロナウイルスの構造データ

+
2020年3月5日: 新型コロナウイルスの構造データ

新型コロナウイルスの構造データ

関連情報:万見生物種 / 2020年8月12日: 新型コロナ情報

外部リンク:COVID-19特集ページ - PDBj / 今月の分子2020年2月:コロナウイルスプロテーアーゼ

+
2019年1月31日: EMDBのIDの桁数の変更

EMDBのIDの桁数の変更

  • EMDBエントリに付与されているアクセスコード(EMDB-ID)は4桁の数字(例、EMD-1234)でしたが、間もなく枯渇します。これまでの4桁のID番号は4桁のまま変更されませんが、4桁の数字を使い切った後に発行されるIDは5桁以上の数字(例、EMD-12345)になります。5桁のIDは2019年の春頃から発行される見通しです。
  • EM Navigator/万見では、接頭語「EMD-」は省略されています。

関連情報:Q: 「EMD」とは何ですか? / 万見/EM NavigatorにおけるID/アクセスコードの表記

外部リンク:EMDB Accession Codes are Changing Soon! / PDBjへお問い合わせ

+
2017年7月12日: PDB大規模アップデート

PDB大規模アップデート

  • 新バージョンのPDBx/mmCIF辞書形式に基づくデータがリリースされました。
  • 今回の更新はバージョン番号が4から5になる大規模なもので、全エントリデータの書き換えが行われる「Remediation」というアップデートに該当します。
  • このバージョンアップで、電子顕微鏡の実験手法に関する多くの項目の書式が改定されました(例:em_softwareなど)。
  • EM NavigatorとYorodumiでも、この改定に基づいた表示内容になります。

外部リンク:wwPDB Remediation / OneDepデータ基準に準拠した、より強化された内容のモデル構造ファイルが、PDBアーカイブで公開されました。

-
万見文献

EMDB/PDB/SASBDBから引用されている文献のデータベース

  • EMDB/PDB/SASBDBのエントリから引用されている文献のデータベースです
  • Pubmedのデータを利用しています

関連情報:EMDB / PDB / SASBDB / 万見 (Yorodumi) / EMN文献 / 新しいEM Navigatorと万見の変更点

他の情報も見る